MASHINIi

Relmada Therapeutics, Inc..

RLMD.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Relmada Therapeutics, Inc. is a late-stage biotechnology company focused on developing novel, proprietary, orally-available, small molecule, product candidates for the treatment of central nervous system (CNS) diseases, including major depressive disorder (MDD) and chronic pain. The company's pipeli...Show More

Ethical Profile

Mixed.

Relmada Therapeutics faces an investigation by the Schall Law Firm for alleged securities law violations related to its RELIANCE III study, which reportedly caused a significant stock price drop. The company maintains an insider trading compliance policy and a whistleblower policy. Relmada focuses on developing therapies for CNS diseases and cancer, addressing significant unmet medical needs. However, the ultimate impact on "Better Health for All" depends on future treatment accessibility and ethical clinical trial conduct. As a clinical-stage biotech, animal testing is a potential aspect of its drug development. Information on environmental impact, worker respect, and community engagement is limited.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-30
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Relmada Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Relmada Therapeutics, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess Relmada Therapeutics, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Relmada Therapeutics, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-30

Relmada Therapeutics, Inc. has not mentioned any financial restatements over the past five years.

1
The company has a whistleblower policy in place, and contact information is provided for requests.
2
Relmada also has a detailed insider trading compliance policy that outlines prohibited activities, blackout periods, pre-clearance requirements for insiders, and penalties for violations.
3
However, this policy is specific to insider trading and does not provide details on broader anti-corruption or anti-bribery measures like FCPA compliance, training frequency, or effectiveness metrics. An independent registered public accounting firm, CBIZ CPAs P.C., is mentioned, but the extent of independent verification of ethical claims or compliance is not specified.
4

Kind to Animals

0

No evidence available to assess Relmada Therapeutics, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Relmada Therapeutics, Inc. on No War, No Weapons.

Planet-Friendly Business

0

The provided articles contain no specific, concrete data points for any of the 'Planet-Friendly Business' KPIs for Relmada Therapeutics, Inc. (RLMD.US).

1
Multiple articles explicitly state that sustainability or environmental data is unavailable or not present.
2
Therefore, no KPIs can be scored based on the evidence provided.

Respect for Cultures & Communities

0

No evidence available to assess Relmada Therapeutics, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess Relmada Therapeutics, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

The provided articles explicitly state a lack of data for all relevant KPIs under the 'Zero Waste & Sustainable Products' value. notes no data on waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, or waste reduction targets.

1
further confirms a complete absence of sustainability data for RLMD.US.
2

Own Relmada Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.